Electrical zaps at home: a new hope for stroke recovery?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥ 18 years with ischemic or hemorrhagic stroke (one month to one year post stroke) 2. Clinical evidence of mild to moderate lower-limb weakness, defined as Manual Muscle Test (MMT) grade 2 or 3 in one or more target muscle groups (e.g., tibialis anterior, quadriceps, hamstrings) on the affected side. 3. Cognitively able to follow instructions and provide informed consent (e.g., MMSE ≥ 24 or equivalent screening, or judged capable by the investigator). 4. Access to a compatible smartphone and home internet service and willing/able to use the tele-rehab app. 5. Skin at electrode application sites intact (no open wounds) and no dermatologic condition that would prevent safe application of the sleeve. Exclusion Criteria: 1. Implanted electronic medical device contraindicated with FES (e.g., pacemaker, implantable cardioverter-defibrillator) or other metallic implants near stimulation site that the treating clinician deems a contraindication. 2. Active seizure disorder (epilepsy) that is uncontrolled or where stimulation could increase seizure risk, diabetes mellitus. 3. Pregnancy or breastfeeding. 4. Known allergy to materials used in the FES sleeve or electrodes. 5. Severe spasticity in target muscle groups (e.g., Modified Ashworth Scale ≥ 3) that prevents functional stimulation or safe participation. 6. Severe cardiovascular instability or uncontrolled medical conditions that make participation unsafe (e.g., unstable angina, recent myocardial infarction within 3 months, uncontrolled hypertension-systolic \>180 mmHg or diastolic \>110 mmHg at screening). 7. Severe cognitive impairment, active psychiatric illness, or communication barriers that preclude safe device use or reliable consent/assessment. 8. Open wounds, skin infection, severe dermatitis, or other skin conditions at electrode or sleeve contact sites. 9. Participation in another interventional trial that would conflict with outcomes or safety reporting for this sub study.